ARTELO BIOSCIENCES, INC. (18)
Browse by Contract Category
Contracts
-
Registration Rights Agreement between Artelo Biosciences, Inc. and Lincoln Park Capital Fund, LLC, dated May 13, 2022
(Filed With SEC on May 16, 2022)
-
At Market Issuance Sales Agreement between the Company and Ladenburg Thalmann & Co. Inc
(Filed With SEC on April 9, 2021)
-
Amended and Restated Employment Agreement by and between the Company and Gregory D. Gorgas dated August 30, 2019
(Filed With SEC on January 14, 2020)
-
First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute dated January 4, 2019
(Filed With SEC on April 15, 2019)
-
Purchase Agreement between Artelo Biosciences, Inc. and Lincoln Park Capital Fund, LLC, dated May 13, 2022
(Filed With SEC on May 16, 2022)
-
Warrant Agency Agreement
(Filed With SEC on October 14, 2020)
-
Underwriting Agreement dated as of October 9, 2020, by and between Artelo Biosciences, Inc. and Ladenburg Thalmann & Co. Inc
(Filed With SEC on October 14, 2020)
-
Form of Underwriters Warrant
(Filed With SEC on October 6, 2020)
-
Form of Lock-Up and Voting Agreement
(Filed With SEC on October 6, 2020)
-
Form of Common Stock Warrant
(Filed With SEC on October 6, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on October 6, 2020)
-
Equity Distribution Agreement by and among the Company and Maxim Group LLC dated as of April 13, 2020
(Filed With SEC on April 15, 2020)
-
Amended and Restated Employment Agreement by and between the Company and Gregory D. Gorgas dated August 30, 2019
(Filed With SEC on November 25, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on June 20, 2019)
-
Form of Warrant Agency Agreement
(Filed With SEC on June 20, 2019)
-
Form of Underwriters Warrant
(Filed With SEC on June 20, 2019)
-
Form of Public Warrant
(Filed With SEC on June 20, 2019)
-
First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute, dated as of January 4, 2019
(Filed With SEC on April 1, 2019)